版本:
中国

BRIEF-Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of Piclidenoson

June 8 Can Fite Biopharma Ltd

* Can-Fite concludes successful clinical investigator meeting for its acrobat phase III trial of piclidenoson in the treatment of rheumatoid arthritis Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐